Haemonetics Corp.


Market Cap$3.8B

Compare Haemonetics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Haemonetics Corp.Haemonetics Corp.30.10%13%30.9
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Current Fair Value

4% upside

Undervalued by 4% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.80 Billion
Enterprise Value$4.48 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$2.46
Outstanding Shares50,786,117
Avg 30 Day Volume580,815


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio30.05
Price to Sales2.97
Price to Book Ratio4.13
Enterprise Value to Revenue3.53
Enterprise Value to EBIT24.81
Enterprise Value to Net Income35
Total Debt to Enterprise0.19
Debt to Equity0.92

Revenue Sources

No data

ESG Score

No data

About Haemonetics Corp.

CEO: Christopher Simon